Moximed develops and manufactures implantable devices for knee osteoarthritis treatment. The company focuses on providing outpatient treatment options that aim to improve quality of life for patients with knee pain who are not yet candidates for knee replacement surgery.

Moximed

Runway Growth Capital

New Enterprise Associates

GBS Ventures

Vertex Ventures

Morgenthaler Ventures

Advent Life Sciences

Future Fund

Gilde Healthcare

Ischyros New York

#NEWS: We’ve secured #SeriesD financing for $91 million: https://lnkd.in/eYh3WgxQ 

Funds will be used to accelerate U.S. commercialization of the MISHA® Knee System. 
 
We’re grateful for the support from lead investor Elevage Medical Technologies, new investors Cormorant Asset Management, LP, Warren Point Capital, and existing investors New Enterprise Associates (NEA), Future Fund, Advent Life Sciences, Glide Healthcare, Vertex Ventures HC, GBS Venture Partners, and Morgenthaler.
 
#Financing #MedTech #MoveToMISHA #KneeOA #Orthopedics #SportsMedicine

Join us in congratulating Dr. Alexander Golant of NYU Langone Health on making the #MoveToMISHA! 👏
 
“The MISHA® Knee System is an excellent option for the right patient,” he said. “It just makes sense in so many ways – avoidance of premature arthroplasty, simple recovery process, and potential for significant pain relief and improvement in function, even with moderate and high-intensity activities. I am excited to have this new instrument in my surgical toolbox.”
 
#MovedToMISHA #Orthopedics #SportsMedicine #KneeOA

We are still buzzing from an exciting #AOSSM2024 last week! 

• Thursday morning Dr. Andreas Gomoll and Dr. David Diduch led a jampacked cadaver lab demonstration

• Thursday evening Dr. Sabrina Strickland and Dr. Cassandra Lee led an exceptional dinner program with The FORUM, a national group of female Orthopedic Surgeons

• Friday morning Dr. Alexander K. Meininger, M.D. FAAOS and his patient, Joe (7-months post-op), led the Moximed team on a leisurely 4-mile run through Denver, and both of them were interviewed by the Denver NBC affiliate KUSA-TV, 9NEWS 

• Friday morning Dr. jason dragoo, Dr. Seth L. Sherman and Dr. David Diduch shared their knowledge and expertise during a presentation in the exhibit hall

We sincerely appreciate the support of the American Orthopaedic Society for Sports Medicine and all of the early adopters who helped educate surgeons interested in treating patients with medial #KneeOA with an implantable shock absorber. 

#MOVEtoMISHA

Christopher Kaeding Eric McCarty Peter A Indelicato MD Moximed OLC Education and Conference Center

“Every new medical technology begins with innovators who dare to challenge the status quo, and this spirit of moxie is something I will continue to push for in this role.”
 
Christopher Gleason, new President and CEO of Moximed, shares his thoughts as this new chapter begins. Check out his article below. 👇
 
#SportsMedicine #Orthopedics #MoveToMISHA #Leadership #MedTech

https://lnkd.in/eQPa97aa

Dr. Seth L. Sherman of Stanford Health Care is among the first surgeons in the country who #MovedToMISHA! 🙌 
 
“The MISHA® Knee System is a game changer for my ‘tweener’ population with medial knee osteoarthritis - too young and active for joint replacement, but poor candidates for other joint preservation strategies. I am excited to offer this generational technology to many more patients over time.”
 
Learn more about MISHA: https://moximed.com/misha/
 
#MoveToMISHA #KneeOA #Orthopedics #SportsMedicine

Congratulations to Justin Saliman, MD on joining the first group of surgeons in the country who #MovedToMISHA! 👏 
 
“We must set our sights beyond temporary fixes. The true aim lies not in merely pushing problems ahead but in safeguarding the very joints that carry us forward. With the MISHA® Knee System, my OA patients are not just able to preserve their knee joint, but they’re able to quickly get back to the activities they love.”
 
Find out more about MISHA: https://moximed.com/misha/
 
#MoveToMISHA #KneeOA #Orthopedics #SportsMedicine

KineSpring

Domain Not Resolving

DNSSEC

Amazon

IPv6

CloudFront

ASP.NET

Amazon Virginia Region

Microsoft

Ruby on Rails Token

Anton Clifford

Consulting CFO

Dan Murray

Director-Hr, Legal, Facilities & Administration

Christine Barcelos

Senior Vice President US Commercialization

Jim Dulaney

Vice President Marketing and Business Development

Keith Fong

Regulatory Counsel and VP Quality

Nancy Isaac

Senior Vice President Operations and Product Development

Wendy Sawyer

Director of R&D

David Lowe

Managing Director, Europe

Luigi Bivi

Director of Operations

Paul O'Connor

Lu Yoh-Chie

Shahzad Malik

Brigitte Smith

John Nehra

Michael Wasserman

Lori Hu

Josh Makower

Founder & Chairman

James Leech

Chief Financial and Strategy Officer

VP Marketing and Business Development

VP Corporate Operations

Founder and Chairman

California Late Stage Companies

Medical Device Companies With Less Than $10M in Revenue (Top 10K)

California Companies With Less Than $50M in Revenue (Top 10K)

West Coast Companies With More Than 10 Employees (Top 10K)

Moximed focuses on enhancing care for patients suffering from osteoarthritis, particularly through the MISHA Knee System. This system offers an outpatient treatment option for those who have not found relief from other therapies and are not candidates for knee replacement. The company aims to improve patients' quality of life by addressing their specific needs and challenges.~~~

Elevage Medical Technologies

Series D - Moximed

Series C - Moximed

Debt Financing - Moximed

Series B - Moximed

Venture Round - Moximed

Series A - Moximed

Seed Round - Moximed

Hayward

California

United States

North America

Michael Mydra Joins Moximed as Senior Vice President of Reimbursement and Market Access

The Week’s 10 Biggest Funding Rounds: Cybersecurity Leads With Kiteworks’ Nearly Half-Billion-Dollar Deal

Moximed Completes $91M Series D Financing

Moximed Scoops Up $91M Series D

Moximed, Inc. Names Christopher Gleason as Chief Executive Officer

Moximed names Christopher Gleason as CEO

James Leech Joins Moximed as Chief Financial and Strategy Officer

An implantable shock absorber designed to unload the knee, relieve pain, and improve function for patients with medial knee osteoarthritis.

Manages support functions essential to sales force productivity, including planning, reporting, quota setting and management, CRM and sales process optimization.

Works within a regulated quality system environment to develop Moximed’s joint unloading technology, focusing on product improvements and verification/validation against user needs.

Responsible for customer relationship management, leading the launch and sales of the MISHA Knee System, and driving product utilization and patient care.

news impact assignment basic	general
public peers	general	Aug 20, 2024 6:07 PM	706fa9d5
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	95fd8ce7
crunchbase profile	general	Nov 25, 2024 9:24 AM	177d84da
li profile	general	Aug 20, 2024 6:07 PM	b058f63f
translate crunchbase fundingrounds	general	Nov 25, 2024 2:02 PM	a3a53f40
peers	general	Aug 20, 2024 6:07 PM	f33eadce
news basic	general	Aug 20, 2024 6:07 PM	789e2e5f
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:MOXIMED

Moximed